Journal Information
Download Cover

Journal of Epileptology is an international, peer-reviewed scientific journal that publish articles in all areas of experimental and clinical epilepsy. Journal of Epileptology is issued on line in electronic form at www.journal-epileptology.com, a primary version, and in paper copies 2 times per year.

The Journal of Epileptology editors endorse the principles embodied in the Declaration of Helsinki and expect that all investigations involving humans will have been performed in accordance with these principles. For animal experimentation reported in the journal, it is expected that investigators will have observed the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education issued by the New York Academy of Sciences Ad hoc Committee on Animal Research. All human and animal studies must have been approved by the investigator’s institutional bioethic review board.

Review process

Received manuscripts are first examined by the Journal of Epileptology editors. Manuscripts with insufficient priority for publication are rejected promptly. Incomplete packages or manuscripts not prepared in the advised style will be sent back to authors. The authors are notified with the reference number upon manuscript registration at the Editorial Office. The registered manuscripts are sent to 3 or more independent experts for scientific evaluation accordingly to double-blind review process. Depending on the reviewers’ opinions and recommendations, manuscripts are returned to the author for corrections and then again back to the reviewers. The author is asked to submit a list of changes or a rebuttal against each point which has been raised by the reviewer. The revised manuscript is finally evaluated by the Editor-in-Chief who considers the reviewers’ comments and his own opinion before passing a decision to the author. The average time from submission to acceptance for on-line publication is up to 2 months

Conflict of interests

Authors of research articles should disclose at the time of submission any financial arrangement they may have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Conflict of interests should be clearly stated at the end of manuscript, just prior to the Reference list.
Journal policy requires that reviewers, associate editors and editors reveal in a letter to the Editor-in-Chief any relationships that they have that could be construed as causing a conflict of interest with regard to a manuscript under review. The letter should include a statement of any financial relationships with commercial companies involved with a product under study.

Permissions

Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission to the Journal for reproduction. Obtain permission in writing from at least one author of papers still in press, unpublished data, and personal communications.

Patients confidentiality. Changing the details of patients in order to disguise them is a form of data alteration. However, authors of clinical papers are obliged to ensure patients privacy rights. Only clinically or scientifically important data are permitted for publishing. Therefore, if it is possible to identify a patient from a case report, illustration or paper, Journal of Epileptology Editors ask for a written consent of the patient or his/her guardian to publish their data, including photograms prior to publication.
The description of race, ethnicity or culture of a study subject should occur only when it is believed to be of strong influence on the medical condition in the study. When categorizing by race, ethnicity or culture, the names should be as illustrative as possible and reflect how these groups were assigned.

Open Access Agreement

Upon acceptance, authors are required to complete Open Access Agreement and send signed document to the editorial office.

Open Access License

This journal provides immediate open access to its content under the Creative Commons CC BY-NC 4.0 license on the principle that making research freely available to the public supports a greater global exchange of knowledge. Under the CC BY-NC 4.0 license users are free to share the work (copy and redistribute the material in any medium or format), if the contribution is properly attributed and used for non-commercial purposes. The material published in the journal may not be altered or build upon.

Disclaimer

Every effort is made by the Publisher, Editors, and Editorial Board to see that no inaccurate or misleading data, opinion or statement appear in the Journal of Epileptology. However, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the responsibility of the contributor, sponsor or advertiser concerned. Accordingly, the Publisher and the Editorial Board accept no liability whatsoever for the consequences of any such inaccurate of misleading data, opinion or statement. Every effort is made to ensure that drug doses and other quantities are presented accurately. Nevertheless, readers are advised that methods and techniques involving drug usage and other treatments described in this Journal, should only be followed in conjunction with the drug or treatment manufacturer’s own published literature in the readers own country.

Publishing model and authors fees

The submission and peer-review of manuscripts are free of charge.

eISSN:
2300-0147
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, other, Neurology, Pharmacology, Toxicology, Pharmacy, Clinical Pharmacy